Delivery Order SPE2DB22D2006-SPE2DB25FW0WU
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$63K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,717.80 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,284.74 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,664.24 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a diabetes medication. The contract has an ultimate completion date of May 7, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,263.07, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. It is a firm-fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,051.59, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $74,297.65 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a period of performance through September 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,160.24 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, with a period of performance ending on April 14, 2023. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $2,902.70 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of...
This federal contract award, valued at $12,077.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a diabetes medication, with a performance period through April 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $22,996.16 firm-fixed-price delivery order is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a broad range of medical...